Home
>
National Drug Code (NDC)
>
PedvaxHIB
PedvaxHIB - 0006-4897-00 - (Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate))
Drug Information of PedvaxHIB
| Product NDC: | 0006-4897 |
| Proprietary Name: | PedvaxHIB |
| Non Proprietary Name: | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) |
| Active Ingredient(s): | 7.5 ug/.5mL & nbsp; Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PedvaxHIB
| Product NDC: | 0006-4897 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103237 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19891220 |
Package Information of PedvaxHIB
| Package NDC: | 0006-4897-00 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) > .5 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of PedvaxHIB
| NDC Code | 0006-4897-00 |
| Proprietary Name | PedvaxHIB |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) > .5 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0006-4897 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19891220 |
| Marketing Category Name | BLA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN |
| Strength Number | 7.5 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
